• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.60% Nasdaq Down 0.39%

    Hemispherx Biopharma, Inc. (HEB)

    -NYSE MKT
    0.12 Down 0.00(1.51%) Feb 11, 4:02PM EST
    Prev Close:0.12
    Open:0.11
    Bid:0.10 x 3500
    Ask:0.13 x 10000
    1y Target Est:0.96
    Beta:-0.988979
    Next Earnings Date:N/A
    Day's Range:0.11 - 0.12
    52wk Range:0.06 - 0.29
    Volume:481,653
    Avg Vol (3m):640,077
    Market Cap:29.08M
    P/E (ttm):N/A
    EPS (ttm):-0.07
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for HEB

    Comparison

    Symbol% ChgMkt Cap
    HEBDown 1.51%29.08M
    GILDDown 0.50%124.23B
    MRKDown 1.37%136.46B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):202.25
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (Dec-14) :N/A
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the Un... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback